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Abstract 
 
The aim of the project was the development of a technique by 
which a subgenomic set of target sequences could be captured 
in order to be analysed by next-generation sequencing 
technology.  
The technique involved two rounds of filter hybridization 
enrichment by which genomic DNA fragments of interest were 
captured, followed by MAPH (Multiplex Amplifiable Probe 
Hybridization) for evaluation of the enrichment. Enriched 
genomic DNA was cloned and sequenced, for the level of 
enrichment to be estimated.  
After two rounds of enrichment for human MSH2 exons, 
approximately 90% of the total cloned sequences were found to 
contain sequences of interest, equal to an enrichment of 
600,000 times. 
The new technique was therefore shown to be efficient with 
high specificity and could be used as a potential clinical 
diagnostic tool. 
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 Chapter 1  
Introduction 
 
 
1.1 Human Genetic Variation 
 
With the development of DNA sequencing techniques and of 
technology in molecular biology it has been determined that two 
randomly -selected human genomes are approximately 99.9% 
identical ( Feuk et al. 2006). That 0.1% difference is 
responsible for the different phenotypes of humans, and there 
is evidence which suggests that genome variability might be 
responsible for a number of genetic diseases, such as cancer, 
diabetes, muscular dystrophies and others (Shaikh et al. 2009). 
Copy number variations involve about 5-12% of the human 
genome (Kato et al. 2009, McCarroll et al. 2008 and Redon et 
al. 2006). Genome variation occurs in variable types, such as 
variable number tandem repeats, single nucleotide 
polymorphisms and others as can be seen in Figure 1. In the 
current research project a novel method for capturing specific 
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regions, for next generation sequencing analysis was 
developed. 
.  
Figure 1. A summary of the variations which are present in the 
human genome.  
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1.2 High- Throughput sequencing 
 
1.2.1 Next generation Sequencing 
 
The analysis of the human genome was always challenging 
and a great ambition for scientists. The development of DNA 
sequencing technologies in the past few years has allowed 
DNA sequencing to be done with low cost and high efficiency. 
That high-throughput technology is generally known as next 
generation sequencing technology (Shendure and Ji 2008).  
DNA sequencing can provide valuable information about 
essential biological processes such as protein- DNA 
interactions and chromosome conformation. In addition to that, 
with the analysis of the whole human genome sequence, 
polymorphisms and mutations can be discovered and with the 
development of ultra- deep sequencing it would in principle be 
possible to develop personal medical treatment and diagnostics 
(Ansorge 2009). 
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              1.2.2 Sanger Sequencing 
 
Since 1977 the main technique for DNA sequencing has been 
the Sanger method. That method is based on sequencing by 
synthesis, where termination is used to identify the nucleotides. 
The DNA strands are denatured and a primer binds next to 
VHTXHQFHRILQWHUHVWLQVXFKPDQQHUWKDWWKH¶HQGRIWKH
primer is attached right at the beginning of the sequence of 
interest. Sanger sequencing requires four distinct reactions in 
its original form as seen in Figure 2. Each reaction consists of 
the sequence of interest with its primer, DNA polymerase, four 
dNTPs and ddNTPs at about 1% of the concentration of 
dNTPs. The major difference between dNTPs and ddNTPs is 
WKDWGG173VFRQWDLQD¶+LQVWHDGRI¶2+7KDWVPDOO
difference is vital for sequencing, because in each cycle the 
primer extension is terminated by the use of fluorescent 
labelled dideoxynucleotides (ddNTPs) (Russel 2002, Sanger et 
al. 1977). Once the dideoxynucleotide (ddNTP) is incorporated, 
the growing chain is fluorescently labelled and because it lacks 
DK\GUR[\OJURXSDWWKH¶HQGWKHFKDLQFDQQRWEHIXUWKHU
elongated and therefore is terminated. The sequence is then 
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identified by high- resolution polyacrylamide gel 
electrophoresis. The fragments are distinguished according to 
their lengths and their fluorescent last nucleotide can be 
identified by laser excitation (Shendure and Ji 2008, Primose 
and Twyman 2003 and Russel 2002). 
                         
                          
Figure 2. The Sanger method, the first DNA sequencing technique 
which can succeed in reading lengths up to 1000bp, includes four 
types of reaction each of which contains a different labelled ddNTP. 
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Once the reaction started and a ddNTP is incorporated the 
elongation is terminated. The identification of the different ddNTPs 
which were incorporated is achieved by gel electrophoresis, where 
the different chains are distinguished according to their length 
(Shendure and Ji 2008). 
 
1.2.3 Roche/454 FLX pyrosequencing 
 
The Sanger method was the main method with which 
fragments of DNA could be sequenced until 1985, when the 
Roche/454 FLX pyrosequencing basic principle was first 
described (Nyren and Lundin 1985). The 454 pyrosequencing 
was the first next generation sequencing technique described. 
In that technique, microscopic beads which are covered with 
DNA primers are mixed with DNA fragments which allow the 
binding of the DNA fragments to the one end. Every bead 
contains product from one DNA fragment. The DNA binding is 
followed by emulsion PCR and after a appropriate number of 
cycles every bead contains thousands of copies of the same 
DNA fragment (Zhou et al. 2010). The beads eventually are 
placed on a picotiter plate array and each hole is expected to 
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contain only one bead. Also, even smaller beads which contain 
a number of enzymes that are required for pyrosequencing are 
placed on the plate (Mardis 2008). During pyrosequencing, 
deoxyribonucleotide triphosphates are added sequentially, and 
incorporation is followed by release of pyrophosphate in equal 
amount to the amount of the incorporated nucleotide as seen in 
Figure 3. Pyrophosphate is then converted by ATP sulfurylase 
WR$73LQWKHSUHVHQFHRIDGHQRVLQH¶SKRVSKRU\ODVH7KH
ATP which is generated converts luciferin to oxyluciferin which 
produces visible light. The light is then detected by a charge- 
coupled device and peaks are generated which indicate the 
number of nucleotides incorporated.(Shendure and Ji 2008, 
Ansorge 2009).        
  
The most important drawback of this technology is in 
sequencing repetitions of the same base, because every base 
is identified by its light signal, and with a long sequence 
consisting of the same bases, their accurate number is in 
general difficult to discriminate (Shendure and Ji 2008). 
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Figure 3.  454 pyrosequencing is the first next -generation sequence 
technique, and uses the generation of visible light for the 
identification of DNA sequence. The beads with the DNA fragments 
on are placed on a picotiter plate which consists of thousands of 
Light 
Every addition of a base by 
polymerase leads to the release of 
a pyrophosphate group which can 
be detected in the form of light 
After many cycles of emulsion PCR 
the beads are covered by thousands 
of copies of the same DNA sequence 
The beads are placed into arrays, 
a picotiter plate which consists of 
thousands wells. Each well is 
occupied by a single bead 
Wells  also contain 
Beads with enzymes 
which are required for 
sequencing 
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microscopic wells organized in an array, so every well contains only 
one bead. Every well is connected with a charge coupled device. 
Therefore, approximately 400,000 reads of 200 to 300 bp per run can 
be achieved and despite the fact is relatively more expensive than 
the other next generation sequencing techniques, this is ideal in 
experiments where long reads are required (Shendure and Ji 2008 
and Zhou et al.2010). 
  
1.2.4 Illumina Solexa sequencing 
 
The Illumina Solexa is another technique for next generation 
sequencing analysis, which was introduced in early 2007. 
Illumina like other DNA sequencing methods is based on 
sequencing by synthesis. In that method DNA fragments are 
ligated at both ends with adapters and fixed on a solid support 
which has on its surface a great number of the complementary 
adapter. The DNA fragments form bridges with the free 
complementary adapters. Then PCR occurs for several and 
cycles and clusters of 1000 copies of single stranded DNA are 
generated on the surface. In order for the sequencing process 
to begin a primer which is required for sequencing binds to a 
universal sequence and the sequencing is initiated (Zhou et al. 
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2010). The clusters of the DNA sequences are present on the 
surface of a glass flow cell. Every lane contains primers which 
are complementary to those on the DNA library (Mardis 2008). 
The identification of the DNA sequences is accomplished with 
the use of reversible terminator nucleotides which are labelled 
with different fluorescent dyes.  The labelled terminator 
nucleotide can be detected after every incorporation, by a 
charge coupled device. The terminator group is then removed 
as well as the fluorescent label and the synthesis cycle is 
repeated as seen in Figure 4. It is powerful technique which 
can analyse more than 40 million polonies in parallel. On the 
other hand, the major limitation of the technique is the average 
size of read length which is approximately 40bp and is relatively 
short, and the technique is susceptible to errors which 
accumulate as the DNA strands are elongated (Shendure and 
Ji 2008, Ansorge 2009 and Zhou et al. 2010). 
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(Ansorge 2009) 
Figure 4. Illumina sequencing is a relatively new technique where 
reads up to 36 bp can be easily sequenced which makes Illumina 
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ideal for experiments which require sequencing of short reads 
(Ansorge 2009). 
 
1.2.5 SOLID Sequencing 
 
In addition to Illumina, a more recent technique is the ABI 
SOLiD sequencing system. In this method adapters are ligated 
to DNA fragments and then bound to beads. Then the DNA 
fragments are amplified by emulsion PCR. The beads with the 
fragments are then placed onto a glass surface where primers 
are hybridized to adapters in addition to oligonucleotide 
octamers which also hybridize to the DNA sequence. The 
fourth and fifth nucleotide of the octamer are determined once 
the fluorescent label, at the four nucleotides at the end of the 
octamer is detected. After ligation the nucleotides after the fifth 
one are cleaved off, removing the fluorescent label and the 
cycles are repeated. In order for the nucleotides in between to 
be identified, shorter primers are used and the same process is 
repeated as can be seen in Figure 5. SOLiD sequencing is a 
powerful method which can analyse up to 10 Gigabases per 
run with an average read length of approximately 30bp 
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(Shendure and Ji 2008, Ansorge 2009, Mardis 2008 and Zhou 
et al. 2010).   
The major advantage of the technique is accuracy, as every 
based is measured twice because of the use of different size of 
primers in order the full length of the sequence to be covered. 
On the other hand, the read length in comparison with the other 
sequencing techniques is relatively short and that is indicated 
as the main drawback of SOLID sequencing (Zhou et al. 2010). 
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 (Ansorge W. J. 2009) 
Figure 5. SOLiD sequencing is a low cost sequencing technique 
compared to the other next generation sequencing methods, with 
very low error rate. However, emulsion PCR is technically 
challenging which makes the application of the technique more 
difficult. (Shendure and Ji 2008) 
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1.2.6 Heliscope Sequencing 
 
Highly parallel sequencing by synthesis was a technological 
revolution and therefore is the basic method of sequencing of 
the majority of next generation sequencing technologies. 
However, has several drawbacks related to the inaccuracy of 
the DNA synthesis. Errors can be introduced during the 
amplification and potential loss of synchronicity in synthesis can 
lead to accumulation of errors. Therefore, single-molecule 
sequencing (SMS) was developed, a technique which has 
overcome those limitations (Gupta 2008). Heliscope single- 
molecule sequencing is a novel technique for next-generation 
sequencing which uses the same general principle as Illumina 
sequencing but with the difference that no amplification is 
required. Primers are hybridized to the DNA sequence which is 
on a glass support with labelled nucleotides and DNA 
polymerase. The labelled nucleotides are incorporated as the 
primers are extended, as Illumina sequencing, every 
incorporation produces visible light which can be detected by a 
charge coupled device (Shendure and Ji 2008, Ansorge 2009).
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(Snyder M. et al. 2010) 
Table1. The properties of next generation sequencing techniques  
On the other hand, the most important limitation of next 
generation sequencing technologies is the high cost per run. 
Next-generation technologies have improved the accuracy and 
read length of sequencing, but the cost still remains high. It is 
estimated that for sequencing of 100 genes from 100 samples, 
where every gene contains 10 exons, the cost can vary from 
$300,000 to approximately $1,000,000 (Shendure and Ji 2008).
  
 
1.2.7 Personal Genomics 
 
Next-generation sequencing of the human genome can identify 
variants of 1% frequency as well as somatic mutations. It has 
been shown that the genetic basis of the majority of common 
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diseases is polygenic and much remains to be discovered 
about their aetiology of these diseases. The development of 
sequencing technologies allows the personal sequencing of 
many individuals, aiming to provide valuable information related 
to gene regulation, chromosome structure and the genetic 
basis of diseases (Snyder et al. 2010). A characteristic example 
is the sequencing of the genomic DNA of tumour and healthy 
skin cells from an individual with M1 subtype of acute myeloid 
leukaemia (AML) (Ley et al. 2008). The study identified ten 
non-synonymous somatic mutations. Two of them were an 
internal tandem duplication of FT3 and a four-base insertion in 
exon12 of the NPM1 gene. Those mutations were common in 
approximately 30% of AML tumours and were considered to be 
responsible for the progression of the disease. The eight 
remaining mutations were all single base changes and were 
considered to be strongly associated with cancer pathogenesis. 
It was important that they had not been detected in an AML 
genome before (Ley et al. 2008). Therefore personal 
sequencing can provide valuable information about the genetic 
mechanism of the diseases. In addition to that, personal 
sequencing has also been used for the construction of a 
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detailed catalogue for somatic mutations from human cancer 
genomes. That catalogue was constructed from mutations that 
were recorded from COLO-829 cell line (Table 2).   
 
(Pleasance E.D. et al. 2010) 
Table 2. Catalogue with the somatic mutations which were found in 
COLO-829 cell line 
The sequencing of individuals in the future will give the 
opportunity for the creation of many catalogues which will 
provide with valuable information related to DNA damage, 
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mutation and repair of DNA that are associated in human 
cancer cases (Pleasance et al. 2010). 
Moreover, current drug treatment does not work with all 
individuals due to genetic variability; the same drugs can be 
beneficial for some individuals but the same time can be 
harmful for others (Ginsburg and McCarthy 2001). Therefore 
human genome sequencing may enable better understanding 
about the cause of the diseases and is a new opportunity for 
the generation of more effective treatment (Guttmacher et al. 
2010). A significant example is the genome sequencing of a 40 
year old individual, the family of whom had history of early 
sudden death and vascular diseases. The genome sequencing 
identified, apart from the variants and SNPs which were related 
to sudden cardiac death and cardiopathies, 63 
pharmacogenomic variants and SNPs which were associated 
with drug response. The individual was found to have variations 
associated with low maintenance dose of warfarin. Therefore, 
for this individual a future potential drug treatment with warfarin 
should be dose modified with lower expected doses (Ashley et 
al. 2010).  Recent sequencing and comparison the genome of 
two different individuals where the first was healthy and the 
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second was diagnosed with acute myeloid leukaemia is a 
significant example of the potential benefits the personal 
sequencing comparison may have (Ley et al. 2008). In addition 
to that, the sequencing of a heavy smoker Chinese individual 
identified variant alleles that were risk factors in tobacco 
addiction (Stevens et al. 2008). Also, physical mapping can be 
achieved by DNA sequencing and enables the recording and 
identification of the different loci which are responsible for the 
different physical characteristics and can be useful for animal 
and plant breeding programmes.  Human genome sequencing 
can use DNA and RNA information for better understanding of 
biological systems. A significant example is the sequence of the 
genome of a male Yoruba from Nigeria, where approximately 4 
million SNPs were identified. In addition has been shown that 
this genome from Yoruba individual shows higher frequency of 
polymorphism than a genome from an individual with European 
origin. Also 153 premature termination codon SNPs were 
considered to affect protein function (Bentley et al. 2008).  
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1.2.8 1000 Genome Project 
Finally, as new DNA sequencing techniques are developed 
they are expected to reduce the cost of sequencing and 
increase its efficiency even more. In addition to that a personal 
genomics project which aims to sequence 1000 human 
genomes is already in progress which promises to reveal many 
secrets related to diseases and human evolution (Ansorge  
2009). The 1000 genomes project is aiming to identify the 
majority of genetic variations that appear to be present at more 
than 1% frequency in the human populations. The identification 
of the potential variation will be a crucial step for the discovery 
of disease causing genes and will provide valuable information 
related to the evolution of the human genome, as the project is 
an international collaboration with genomes from all the 
continents. In the future, that knowledge could become 
beneficial in clinical medicine, for prediction of disease 
susceptibility and discovery and response. The first results from 
the 1000 genome project were so far from the pilot 1 analysis. 
The outcome was so far encouraging, with more than 9 million 
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SNPs, numerous new indels and few large structural variants 
identified (Via et al. 2010).     
However, the genomic information can be psychologically 
harmful for the individuals examined. In general, patients tend 
to exaggerate genetic predictions, which might cause panic and 
fear for the rest of their lives. (Ransohoff and Khoury 2009 and 
McGuire et al. 2008)  
  
1.2.9 Exome Sequencing 
 
As described above, genetic variants could be vital for the 
understanding of rare and common diseases. Therefore, the 
sequencing of only the protein-coding genes has been shown 
to be ideal for the identification of rare variants with high 
specificity and reduced cost which makes the technique a 
powerful clinical diagnostic tool. The exome which consists of 
the protein coding genes represents 1% of the human genome. 
Also, it has been considered that about 85% of the disease-
causing mutations are located in the coding regions or the 
canonical splice sites (Ng et al. 2010, Ng.et al. 2009, Choi M. et 
al. 2009).   
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Exome sequences can be captured with the use of a human 
exome oligonucleotide array and sequenced with Illumina next-
generation sequencing technology. The genomic DNA is 
fragmented with sonication and adapters which contain primer 
site sequences are ligated to the DNA fragments. Those 
fragments are then separated according to their size by gel 
electrophoresis and the desired size DNA is extracted from the 
gel. The fragments are then PCR amplified and hybridized to 
the exome array which can capture approximately 180,000 
coding exons with the use of 2.1 million probe array. The array 
can capture with high specificity of approximately 90% (Hedges 
et al. 2009).  The captured fragments are then sequenced 
using Illumina sequencing technology. The process is relatively 
simple and less expensive as the fragments are only the exome 
and not the whole genome and also because Illumina 
sequencing is relatively cheaper than the other sequencing 
techniques (Choi et al. 2009). 
As mentioned above, exomes are captured by an array based 
technique, where genomic DNA is randomly fragmented and 
ligated to specific linkers in order to become amplifiable are 
hybridized to exon tiling arrays. The captured fragments are 
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then ligated with specific Illumina 1G linkers and then are 
amplified. The amplified product is placed into a flow cell of 
eight lanes and an in situ amplification occurs in order for 
clusters to be generated. As in other next-generation 
sequencing techniques, after every incorporation of fluorescent 
nucleotide light signal is obtained and the nucleotide is 
identified (Hodges et al.2007). 
Exome sequencing has been used in published studies as a 
clinical diagnostic tool for the identification of rare diseases. 
Patients who were suspected to have Bartter syndrome had 
been examined with exome sequencing which found a 
homozygous missense D652N mutation at a position in 
SLC26A3 which is an extremely conserved position among all 
invertebrates and vertebrates and also, is the known congenital 
chloride diarrhoea locus. The unexpected genetic diagnosis in 
that study of a patient with an undiagnosed illness illustrates 
the clinical implications of exome sequencing as a powerful 
diagnostic tool (Choi et al. 2009).     
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Additional evidence about the efficiency of the method was 
illustrated by studies which proved that with exome sequencing 
candidate genes for Mendelian disorders can be identified by 
sequencing a small number of unrelated, affected individuals as 
illustrated in Figure 6. That study included 12 individuals, eight 
Hapmap individuals and four with Freeman- Sheldon 
syndrome, which is a rare dominant disorder. The comparison 
of exome sequencing with previous genome sequences 
revealed that the technique can be as accurate and efficient as 
whole genome sequencing. Also it has been shown that the 
combination of exome sequencing with the use of bioinformatic 
filters can achieve the direct identification of the gene of 
interest. The exomes from the HapMap individuals were used 
as filters and in addition to the removal of common variants, 
they ended up with a single gene MYH3 which has been shown 
from previous studies to be the causative gene for Freeman- 
Sheldon syndrome (Ng et al. 2009).  
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Figure 6. The stepwise filtering process for the identification of the 
candidate gene 
A similar method has been used for the discovery of the gene 
which is responsible for the Miller Syndrome, a rare Mendelian 
disorder. Four affected individuals were examined, in three 
independent kindreds. A filtering approach was used, in order 
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to exclude a vast number of variants which were unlikely to be 
causative and to focus on a small number of candidate genes. 
They identified eight candidate genes under a dominant model 
and only one (DHODH) under a recessive model. Additional 
screening of three unrelated people with the disorder and a 
sibling of the second revealed a total of 11 mutations in 6 
kindreds with Miller syndrome. Those results were solid 
evidence for the identification of DHODH as causative gene of 
Miller syndrome. That was additional evidence for the potential 
of exome sequencing not only as a diagnostic tool but as a 
powerful technique for the discovery of disease causative 
genes (Ng et al. 2010). The technique of exome sequencing 
was also used in cancer where new somatic mutations have 
been identified. (Choi et al. 2009) 
Exome sequencing might be efficient in identifying genes for 
rare mutations which are located in protein coding regions, but 
cannot identify any structural variants and noncoding variants 
which can be found by whole genome sequencing. Finally, it 
has been illustrated above that has been already been used as 
successful diagnostic tool and with the improvement of the 
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technique event further it could have implications in medical 
care.    
 
1.3 Assessing copy number  
 
1.3.1 Multiplex Amplifiable Probe Hybridization 
 
In order for specific DNA sequences to be analysed by next 
generation sequencing, they have to be identified and captured 
and methods for measuring copy number can be used to 
assess the effectiveness of enrichment. One of the most 
efficient PCR based methods for the identification of copy 
number variants is the Multiple Amplifiable Probe Hybridization 
(MAPH). This is a PCR based technique which relies on the 
principle of the DNA complementarity as illustrated in Figure 7. 
In MAPH the genomic DNA is fixed on a nylon filter. MAPH 
probes for any gene are designed to be of different sizes, in 
order to be able to be distinguished after gel electrophoresis 
and are flanked by the same set of primers so they can all be 
amplified together. MAPH probes hybridize with genomic DNA, 
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binding to the complementary sequences on the filter and the 
unbound DNA is washed with stringent solution. The hybridized 
DNA is then denatured with the use of either high temperature 
or addition of NaOH. The hybridized strands are thus released 
into a buffer solution. The released strands are amplified and 
with the use of gel electrophoresis the hybridized sequences 
can be identified and analyzed for the detection of deletions or 
duplications (den Dunnen and White 2006, Hollox et al. 2002, 
Patsalis et al. 2005, Sellner and Taylor 2004, Tyson et al. 2009 
and XueiMei and HuaSheng 2009).  
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Figure 7. In multiplex amplifiable probe hybridization, genomic DNA 
is fixed onto nylon filters and hybridized with probes which contain 
the sequence of interest. The washing step is vital for the removal of 
background DNA and capture only of the hybridized probes. The 
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captured sequences are then analyzed by ABI electrophoresis for 
the identification of potential deletions or duplications.  
 
For the identification of the possible deletions or duplications 
ABI signals are used for the estimation of the normalised ratios 
for every probe. Controls which were unaffected had a 
normalized mean of 1.0. On the other hand ratios below 0.6 
and over 1.5 were considered as deletions and duplications 
respectively (Hollox et al. 2002). 
 
1.3.2 MAPH as a clinical diagnostic tool 
 
MAPH can be used as useful diagnostic tool for genetic 
diseases where the only mutation is copy number change. 
Significant examples are the deletions or duplications in DMD 
and BRCA1 genes which have been shown to be responsible 
for causing Duchenne muscular dystrophy and breast cancer 
respectively. Also, deletions or duplications of subtelomeric 
DNA are highly associated with congenital abnormalities and 
mental retardation (Hollox et al. 2002). Hereditary non-
polyposis colorectal cancer (HNPCC) has been found to be 
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caused by mutation in four mismatch repair genes (MLH1, 
MSH2, MSH6, PMS2). However, MLH1 and MSH2 contain 
approximately 90% of the mutations that have been detected in 
HNPCC patients (Kohlmann and Gruber 2006). Therefore, 
MAPH was evaluated in its efficiency to identify and discover 
potential deletions or duplications in HNPCC patients. The 
study included 73 control samples which were healthy 
individuals and had no known deletions or duplications and 50 
samples which derived from hereditary non polyposis colorectal 
cancer (HNPCC) patients which had no known point mutations 
according to previous tests with other methods.  The study 
identified exonic deletion in 10 of the samples. Three 
independent mutations and a deletion of exon 3 of the MSH2 
gene have also been found which have been identified also in 
previous studies. Moreover, a deletion has been detected of 
exon 13 of MLH1 gene which has been also found in three 
individuals which were relatives of the patient. Three of the 
patients were discovered to have a deletion in exon 8 of MSH2 
which is considered to be a frequent deletion among HNPCC 
patients as it has been found in other HNPCC patients in 
previous studies.  This study certifies the quality and the value 
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of the results using MAPH technique and proves that MAPH is 
capable for the identification of potential deletions and 
duplications in comparison with the other modern methods 
available (Akrami et al. 2005).It has been noted that early 
diagnosis is vital for the treatment of cancer, and HNPCC gene 
tests are an important tool for early diagnosis, therefore MAPH 
can contribute so the gene test can be more specific and to 
include the maximum number of potential mutations for the best 
diagnosis (The Johns Hopkins University 1995). 
MAPH offers a variety of advantages compared to other 
modern techniques. It is a relatively simple method which does 
not require the use of complex technology; it is cheap and is 
fast with only few days required for a single experiment 
(Patsalis et al.2005 and Hollox et al. 2002). The major 
advantage of MAPH is the great number of loci that can be 
analyzed in a single experiment. An amplification with many 
probes flanked by different primer pairs results in low quality or 
non-amplification. That problem is overcome by generating a 
set with different probes flanked by the same set of primers 
(Armour et al. 2000 and White et al. 2002). Furthermore, MAPH 
probes have been shown to be particularly not susceptible to 
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substitutional polymorphisms, which make them ideal for copy 
number variation identification (Sellner and Taylor 2004). 
 
1.3.3 Disadvantages 
 
MAPH is a convenient technique for copy number detection, 
but has also several limitations. The major drawback of the 
technique is the limited number of probes that can be analyzed 
in a single experiment due to gel electrophoresis. A number of 
100 probes distinguished by 5bp interval have been previously 
analysed simultaneously (Patsalis et al. 2005).  
 
1.3.4 Other Methods for copy number 
determination 
 
Alternative methods include microarray based techniques such 
as comparative genome hybridization (array-CGH) and 
representational oligonucleotide microarray analysis (ROMA) 
and PCR based techniques such as multiplex ligation 
dependent probe amplification (MLPA) and quantitative 
multiplex PCR of short fragments (QMPSF). 
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1.3.5 Array-based comparative genomic 
hybridization (aCGH) 
 
 In array CGH, the reference and test genomic DNA which 
contain the sequences of interest are fluorescently labelled with 
different fluorophores and are then hybridized to arrays which 
contain DNA fragment from various loci in a competitive 
manner. Potential deletions or duplications are then identified 
from resulting hybridization signal intensity of the arrays 
(Kousoulidou et al. 2008 and Feuk et al. 2006). The arrays are 
usually constructed by oligonucleotides from 60 to 100 bp or by 
large genomic clones such as BACs with the size of 
approximately 150 kb (XueiMei and HuaSheng 2009 and De 
Lellis et al. 2007). The major advantage of the technique is its 
ability to assess a great number of loci in a single experiment 
(Vissers et al. 2003). On the other hand the large size of BAC 
probes leads to decreased resolution and in combination with 
its high cost makes the technique inconvenient as a diagnostic 
tool (XueiMei and HuaSheng 2009 and De Lellis et al. 2007). 
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1.3.6 Representational oligonucleotide microarray 
analysis (ROMA) 
 
The principle of representational oligonucleotide microarray 
analysis (ROMA) is similar with the array CGH technique, the 
major advantage in this technique is that the samples are 
simplified before the hybridization process. The genomic DNA 
is first digested with the use of restriction enzymes. The 
fragments are then ligated with specific adaptors which make 
them amplifiable. The amplification step is vital for the process 
as is the stage where the hybridized DNA is simplified. In that 
process due to polymerase enzyme, only fragments with 
maximum length of 1.2 kb are amplified successfully, therefore 
the DNA is simplified by excluded sequences with higher 
number of bases. The test and reference genomic DNA is 
fluorescently labelled and hybridized in arrays which contain 
loci specific sequences. ROMA is sensitive technique which 
can detect copy number changes of even 30kb in the human 
genome.  On the other hand, one of the drawbacks of any array 
technology is that it cannot identify balanced rearrangements in 
the human genome ( Kousoulidou et al. 2008, XueiMei and 
HuaSheng 2009 and Feuk et al. 2006). 
Page 45 out of 132 
 
1.3.7 Multiplex ligation dependent probe 
amplification (MLPA) 
 
Other PCR-based techniques include multiplex ligation 
dependent probe amplification (MLPA) and quantitative 
multiplex PCR (QMPSF). In MLPA, genomic DNA is hybridised 
in solution containing sets of probes. These probes are not 
amplifiable at early stage but are becoming amplifiable later 
stages. Every set consists of two halves. Each half comprises a 
20 to 30 nucleotide long target specific sequence which is 
flanked by universal primer sequence. In the middle of the two 
halves there is a fragment of random length which is used to 
differentiate the size of the probes so they can be used for 
electrophoresis. The probes bind adjacent to the target DNA 
and then are joined together by a ligase. Once the probes are 
adjacent to each other and ligated, are becoming amplifiable 
too. The unbound probe halves are unable to be amplified; 
therefore no washing step is required. With the use of MLPA, 
copy number differences up to 50 regions can be identified 
(Van Eijk et al. 2010). The basic advantages of MLPA over 
MAPH are the relatively small amount of DNA that is required 
which can be only 20ng compared with the 1ȝg of DNA in 
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MAPH, the lack of washing step which makes the technique 
simpler and less susceptible to contaminations and fact that 
MLPA probes become amplifiable only after the ligation step 
which decreases the contamination susceptibility even more. It 
is a low cost and easy in application technique and the kits that 
which are provided by the companies reduce the time that is 
required for the completion of the process to minimum ( De 
Lellis et al. 2007). Also, it is capable in detecting not only large 
copy number changes but small mutations too (Bunyan et al. 
2004). However, the generation of MLPA probes is much more 
complicated than for MAPH probes (Sellner and Taylor 2004 
and Feuk et al. 2006).   
 
1.3.8 Quantitative multiplex PCR of short 
fragments (QMPSF)  
 
The quantitative multiplex PCR of short fragments (QMPSF) is 
another PCR- based technique for the identification of deletions 
or duplications. In that technique, labelled primers are used to 
flank short locus specific genomic DNA sequences.  The 
primers are mixed with genomic DNA and quantitative PCR 
Page 47 out of 132 
 
occurs, which is stopped in log phase and gel electrophoresis 
can identify possible deletion or duplications for each target 
region (Feuk et al. 2006 and De Lellis 2007). With the use of 
short fragments the amplification accuracy is increased and 
therefore better comparison can be achieved. Also, the multiple 
PCR where the fragments are amplified simultaneously 
contributes to the better comparison of the resulted peaks. 
(Charbonnier et al. 2000). 
 
1.4 Project Overview 
 
This project was based on studies which have used filter-based 
hybridization enrichment technique for subgenomic targets to 
be captured. In Herman et al. (2009), filter based hybridization 
was used for the detection of potential single nucleotide 
polymorphisms (SNPs) and copy number variations (CNVs) in 
genes associated with hypertrophic cardiomyopathy (HCM) and 
high density lipoprotein (HDL) cholesterol. 
The principle of filter based hybridization was for the target 
DNA sequence which was to be analysed to be fixed on a nylon 
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filter, so the complementary amplifiable sequences from 
genomic libraries after hybridization and stringent washing 
could be trapped and further analysed for CNV detection as 
seen in Figure 8. 
 
 
(Herman et al. 2009) 
Figure 8. Filter based hybridization: 
Target DNA which was in form of concatemers was fixed on a nylon 
filter. Then genomic DNA is sonicated and cut in pieces 
approximately 150 to 250bp length. The small fragments were then 
blunt ended, phosphorylated and ligated to each other containing 
adaptors in between with 2bp identifying barcodes in order to 
become amplifiable. The ligated amplimers are then denatured and 
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loaded to the appropriate filters. The filters are washed with 
stringent solution for the removal of unbound material. Once the 
bound sequences are selected, they amplified and sequenced for the 
identification of possible SNPs and CNVs.      
 
The results identified 289 SNPs, 238 of which were identified in 
previous studies.  Approximately 20 kb of the subject HCM1 
had been previously sequenced and illustrated complete 
similarity with the sequences analyzed. The results illustrated 
that the technique is powerful in detecting CNVs and more 
specifically deletions over 32bp and insertions over 64bp with 
sensitivity of more than 95%. Also, from the fragments captured 
it has been found that ~58%of the total sequences captured for 
HCM were sequences of HCM genes and ~67% from the 
fragments captured for HDL were sequences of HDL genes, 
which was a very good level of enrichment (Herman et al. 
2009).  
In this project, a filter based hybridization technique was used 
followed by MAPH analysis in order to assess the ability of the 
technique to enrich subgenomic targets. That has been 
achieved with the application of two rounds of enrichment. The 
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level of enrichment has been estimated and with the use of 
site-specific primers followed by various PCR cycles, the 
quantity of the enriched product has been estimated too. The 
results illustrate that high a level of enrichment can be achieved 
with the use only of few pg of enriched product and that with 
the combination of those methods, specific targets can be 
captured from genomic DNA with accuracy and sensitivity.  
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Chapter 2 
Materials and Methods 
 
 
2. 1 Generation of Amplifiable linkered 
genomic DNA 
 
Genomic DNA from two individuals (TT297 and AF103, a male 
and a female respectively) was sonicated by Covaris sonicator. 
In the sonication process, genomic DNA was sheared to 
random size fragments between 100 to 900bp. The sonication 
process used a, 5% duty cycle, intensity 3 and cycle/burst 
intensity of 200 at 4 °C, two times for a cycle of 45 seconds. 
Once the two genomes were sonicated, 100 ȝl of each DNA 
sample were added into a Covaris microtube (6x16 mm AFA 
fiber with snap cap) with the addition of 1ȝl of 100 times TE 
buffer( 1M Tris-Cl, pH 8 and 100 mM EDTA). 
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2.1.1 Size estimation 
 
A 2% agarose gel was prepared in order for the size range of 
the sonicated fragments to be estimated. For the agarose gel 
generation, 100ml of 0.5 x TBE buffer (250ml of 10x TBE, 
500ȝl of 5mg/ml Ethidium Bromide, 5L of deionised water) were 
mixed with 2g of agar. For the gel electrophoresis for each 
sample, 5ȝl were mixed with 2ȝl of loading dye (0.025% 
bromophenol blue dye, 40% sucrose, 25x TBE buffer). The 2% 
agarose gel was electrophoresed at 100V for approximately 1 
hour. 
 
2.1.2 End Repair 
 
Sonication sheared DNA fragments randomly; therefore not all 
blunt ends were generated. In order for the ends of the 
fragments to be repaired, phosphorylated and blunted, 20ȝl of 
10x NEB buffer 2(New England Biolabs), 8ȝl of 10ȝM dNTPs 
(New England Biolabs), 2ȝl of 100ȝM ATP, 40 units of T4 DNA 
polymerase (New England Biolabs) and 80 units of T4 PNK 
(New England Biolabs) were mixed with 48.7ȝl of deionised 
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water in total volume of 100ȝl. The samples were incubated at 
37 °C for 30 minutes. 
 
2.1.3 PCR purification 
 
The two genomic DNA samples (100ȝl) were purified by 
QIAquick PCR purification kit (Qiagen). Therefore, each 100ȝl 
of genomic DNA was mixed with 500ȝl of buffer PB. The mix 
was then applied onto a QIA quick spin column and centrifuged 
for 1 minute at 13,000rpm (maximum speed). The flow- through 
was discarded and then 750ȝl of buffer PE were added and 
centrifuged for 1 minute. The flow through was discarded and 
the tube was centrifuged again for 1 minute with the remaining 
flow through to be discarded again. The QIAquick column was 
then placed on a new eppendorf tube and 30ȝl of elution buffer 
EB were loaded and the tube was centrifuged for 1 minute.  
Once the PCR purification was completed, a gel 
electrophoresis using 2% of agarose gel was repeated in order 
for the efficiency of the purification process to be checked. 
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2.1.4 Ligation 
 
The purified genomic DNA samples were then ligated with 
linkers in order to become amplifiable as indicated in Figure 9. 
From the gel electrophoresis it was estimated that the mix 
consisted of approximately 6ȝg of genomic DNA. Therefore for 
the ligation, 10ȝl of purified solution (containing 2ȝg of genomic 
DNA) were mixed with 2.5ȝl of 10x ligation buffer (NEB recipe), 
2.5ȝl of 10mM ATP, 0.5ȝl of 500ȝM Linker AH1, 0.5ȝl of 500ȝl 
Linker AH2, 2ȝl (2.5units) of T4 DNA ligase (New England 
Biolabs) and 7ȝl of deionised water in a total volume of 25ȝl.  
Three mixes were prepared, one for TT297 genomic DNA, one 
for AF103 and one with only deionised water as control sample. 
The three samples were left at room temperature for an hour 
and then placed at 4°C for overnight incubation.  
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Tyson et al. 2009 
Figure 9. The figure illustrates the sequences of the AH1 and AH2 
linkers with the restriction enzymes sites indicated. The sequences 
of interest were ligated with AH1 and AH2 linkers in order to become 
amplifiable and AH1F and AH2F primers were used for the PCR 
amplification of the fragments.  
 
2.1.5 Ethanol Precipitation 
 
The samples from ligation were ethanol precipitated. To each 
25ȝl of ligated sample 0.5ȝl of 10mg/ml tRNA were mixed to 
act as a carrier, followed by the addition of 75ȝl of 100% 
ethanol. The mixes were placed on ice for approximately 10 
minutes and were then centrifuged for 10 minutes at 13,000 
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rpm. The supernatant was discarded and the tubes were 
centrifuged for an additional minute. The remaining supernatant 
was removed again and then 150ȝl of 80% ethanol was added. 
The tubes were centrifuged for 10 minutes at maximum speed 
and the supernatant was discarded. The remaining pellet was 
resuspended with the addition of 10ȝl of deionised water.  
 
2.1.6 Amplification 
 
In the next stage, the precipitated material which consisted of 
2ȝg of ligated genomic DNA was diluted. Specifically, 1ȝl of the 
precipitated material was mixed with 10ȝl of deionised water to 
result in 20ng/ȝl of genomic DNA. Three samples were 
prepared for the amplification, TT297 genomic DNA, AF103 
genomic DNA and a third sample which was control and 
contained deionised water. The samples were amplified using 
AH1F (ACTGTCCAGCTTCGATGGCC) and AH2F 
(CTAATCGGCCTGTGAGAGCT) primers. For each sample a 
total mix of 19ȝl was prepared consisting of 2ȝl of 10x AB gene 
PCR buffer IV, 0.8ȝl of 25mM MgCl2 (AB gene) , 0.16ȝl of 
25mM dNTPs, 1ȝl of 10ȝM AH1F primer, 1ȝl of 10ȝM AH2F 
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primer, 0.2ȝl of 5U/ȝl Taq polymerase (New England Biolabs) 
and 13.84ȝl of deionised water. For the amplification of the 
samples 25 PCR cycles were used.  The samples were 
incubated before the amplification at 70 °C for 1 minute for the 
polymerase enzyme to fill in the ends of the fragments, followed 
by a 95°C step for 1minute, 60°C for 1 minute and 70°C for 
1minute for 25 cycles. The PCR product was then tested by gel 
electrophoresis using 2% agarose gel.  
 
2.1.7 PCR Efficiency  
 
Once the PCR at 25 cycles was checked and it was ensured 
that 25 cycles were sufficient for the generation of significant 
amount of product, different conditions were applied by 
repeating the same PCR in order to improve the yield. The 
PCR tests were of 4 different kinds, with AB x10 buffer IV (AB 
gene), with 10x PCR buffer (500mM Tris HCl pH 8.8, 120mM 
Ammonium sulphate, 50mM MgCl2, 74mM 2-mercaptoethanol, 
11mM dATP, 11mM dCTP, 11mM dGTP and 11mM dTTP and 
1.25mg/ml BSA), 10 x PCR buffer as above but with 0.4ȝl of 
HiDi formamide and the last was 10x PCR buffer with 2ȝl of 
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glycerol. The test was repeated for both genomic DNA samples 
(TT298 and AF103) at 25 cycles. Once that test was completed 
the same process was repeated but during the PCR the 95°C 
step instead of 1 minute it was used 30 seconds. Also, series of 
tests were prepared using the same PCR conditions at different 
PCR cycles.  
 
2.1.8 Quantification 
 
In order for the yield of the product from the PCR cycle tests to 
be estimated, herring sperm DNA was used. Herring Sperm 
DNA was first cut by HaeIII restriction enzyme in order to 
generate a smear after gel electrophoresis. For the restriction-
cut DNA three different sets were prepared where, 2ȝl of 10x 
NEB buffer2, 2ȝl/5ȝl/10ȝl of 10mg/ml Herring sperm DNA, 0.5ȝl 
of 5 units of HaeIII restriction enzyme and 12.5ȝl/7ȝl/3ȝl of 
deionised water were mixed and incubated at 37°C for 30 
minutes. Once the restriction digest was completed, 0.2ȝl of 
Herring sperm DNA was diluted into 20ȝl of deionised water 
then 0.2ȝl, 0.5ȝl and 1ȝl which are (equal to 200ng, 500ng and 
1ȝg of DNA) were loaded on a 2% agarose gel with the 
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genomic DNA from the previous PCR cycle tests in order for 
their product to be quantified.  
 
2.2 Multiplex amplifiable probe hybridization 
(MAPH) 
 
Genomic DNA or enriched samples from PCR were purified by 
QIAquick PCR purification Kit (Qiagen) and then ethanol 
precipitated. Once the precipitation was completed, 1ȝl of 1M 
NaOH was added to each sample.   
 
2.2.1 Filter preparation 
 
For the hybridization, 10 ~2x4mm nylon filters were cut and 
labelled.  The genomic DNA which was previously precipitated 
was loaded onto the filters (~1ȝg). The DNA was then bound to 
the filter after exposure to 50mJ of UV radiation (Armour et al. 
2000). 
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2.2.2 Filter pre-hybridization 
 
Filters were prehybridised together in a solution which 
contained 1ml of prehybridization solution (0.5M sodium 
phosphate pH7.2, 7% SDS, 0.1 mg/ml alkali-denatured herring 
sperm DNA). The filters incubated at 65 °C for 2 hours. That 
solution was then replaced by 200ml of prehybridization 
solution which contained 10ȝg/ml of denaturated human Cot-1 
DNA (Armour et al. 2000). 
 
2.2.3 Hybridization 
 
 The filters were incubated further at 65°C for approximately 40 
minutes and then were mixed with 1ȝl of 10mg/ml human Cot-
1DNA (Invitrogen), 1ȝl of 10mg/ml of Herring Sperm, 2ȝl of 
250ȝg/ml of ĭȋ174/HaeIII (New England Biolabs), 1ȝl of end 
blocking primers PZA and PZB and 1ȝl of probe mix HNPCC 
which was first denatured by the addition of 2ȝl of1M NaOH 
followed by the addition of the mix to the filters. After 
denaturation, the probes were incubated for 1 minute at 37°C 
and then were placed straight on ice followed by addition of 3ȝl 
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of 1M Na2PO4. The probes were the filters then incubated 
overnight at 65°C (Armour et al. 2000). 
 
2.2.4 Washing 
The filters were washed with the use of two different 
hybridization solutions. The first washing step was with 500ml 
of 1x SSC/1% SDS, followed by washing with 500ml of 0.1x 
SSC/0.1% SDS. Once the washing was completed, each filter 
was transferred into 50ȝl of 1x  buffer IV (ABgene) (Armour et 
al. 2000).The tubes were then incubated for 5 minutes at 95°C 
to release bound probes for amplification. For the amplification, 
for each sample, 2ȝl of 10xPCR mix, 0.8ȝl of 10ȝM HexPZA 
(Hex-AGTAACGGCCGCCAGTGTGCTG) primer, 2ȝl of 10ȝM 
PZB (CGAGCGGCCGCCAGTGTGATG) primer, 0.4ȝl of 
5000U/ml Taq polymerase (New England Biolabs) and 14ȝl of 
deionised water were mixed.  The PCR consisted of 3 steps; 
the first was 30 seconds at 95°C, the second 1 minute at 60°C, 
and the third was 1 minute at 70°C at 25 cycles. Once the PCR 
was completed the samples were incubated at 70°C for 40 
minutes.  
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2.2.5 ABI Electrophoresis 
 
In order for the captured fragment representation to be 
evaluated, it was prepared for ABI electrophoresis. A mix of 2ȝl 
of ROX500 marker (Applied Biosystems) and 170ȝl of HiDi 
formamide per 16 samples was prepared and for each sample 
1.5 ȝl of the PCR product was added to 10ȝl HiDi/Rox 500 
marker. The plate was centrifuged and denatured at 96°C for 3 
minutes. The samples were then electrophoresed on an ABI 
3100 36cm capillary, with the use of POP-4 polymer and 
injection of 45 seconds at 1kV. 
 
2.3 Selection Methods 
 
In this experiment, MLH1 and MSH2 exon probes were 
amplified and 1ȝg of exonic DNA was loaded onto filters in 
order to be hybridized with linkered genomic DNA. The 
captured DNA fragments were then amplified and analysed by 
MAPH. 
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Figure 10.  Distribution of exons across the MSH2 and MLH1genes. 
The exons are illustrated as vertical small lines; adapted from UCSC 
genome browser.  
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2.3.1 First Round of Enrichment 
 
The HNPCC MAPH probe set consists of 16 MSH2 probes, 19 
MLH1 probes and 1 X and 1 Y linked probes. In this experiment 
MSH2 and MLH1 probes were amplified individually and mixed 
into three different groups. For the amplification, for each 
sample, 1ȝl of probe DNA, 2ȝl of 10x PCR mix, 1ȝl of 10ȝM 
PZA primer, 1ȝl of 10ȝM PZB primer, 0.2ȝl of 5000U/ml Taq 
polymerase and 14ȝl of deionised water were mixed. After 
individual amplification all the MSH2 exon probes were mixed 
together and all the MLH1 together. Also, an additional mix was 
prepared which contained only the S11 and S13 exonic probes. 
The three different mixes were then purified by QIAquick PCR 
purification Kit (Qiagen) and the DNA was loaded onto ~2x4mm 
nylon filters. For the first step of the experiment, 11 filters were 
prepared, 3 for MSH2 probes, 3 for MLH1 probes 3 for S11/S13 
probes. Once the DNA was denatured loaded to the 
appropriate filters and crosslinked by 50mJ UV radiation, the 
filters were placed into 3 different tubes which contained 1ml of 
prehybridization solution (See section 2.2.2).  Each tube 
contained 1 filter with MSH2 probes, 1 with MLH1 probes and 1 
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with S11/S13 probes. The first tube was hybridized with TT298 
linkered genomic DNA, the second tube with AF103 linkered 
genomic DNA and the third was a control with no input DNA.  
The filters were incubated overnight at 65°C and then were 
washed with the same washing protocol as for MAPH (See 
section 2.2.4). The filters were placed into 50ȝl of 1x buffer 
solution and incubated at 95°C for 5 minutes to release 
hybridising fragments. The hybridizing DNA was then amplified 
at 25 PCR cycles using AH1F/AH2F primers. The yield of PCR 
was checked by gel electrophoresis and then the PCR product 
was purified by QIAquick PCR purification Kit (Qiagen). 
 
2.3.2 MAPH analysis of enriched DNA 
 
The enriched DNA after purification was denatured with the 
addition of 2ȝl of 1M NaOH and was loaded onto the filters. 
The DNA was then fixed onto the filters by exposure to 50mJ of 
UV radiation. The samples were prehybridized and then were 
hybridized with the HNPCC probe set (2ng each probe) (See 
sections 2.2.2 and 2.2.3). The filters were then stringently 
washed, placed into 50ȝl of 1x buffer solution and incubated at 
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95°C for 5 minutes. The DNA samples were then amplified at 
25 cycles with Hex PZA and PZB primers, followed by 
incubation for 40 minutes at 72°C. The PCR product was then 
analyzed by ABI electrophoresis at 1kV for 45 seconds. The 
DNA from first round of enrichment filters was amplified for 35 
cycles. The samples were purified by QIAquick PCR 
purification Kit (Qiagen). With the use of 2% agarose gel 
electrophoresis the product was quantified. Then 10x and 100x 
dilutions were made which were equal to 100ng and 10ng in 
3ȝl of dilution respectively. The filters were prehybridized and 
hybridized with HNPCC probe set and then stringently washed, 
placed in 50ȝl of 1x buffer solution and incubated at 95°C for 5 
minutes; the released probes were amplified at 25 cycles 
followed by 40 minutes incubation at 72°C and prepared for 
ABI electrophoresis.  
 
2.3.3 Second Round of Enrichment 
 
In the next stage MSH2 and MLH1 probes were prepared 
exactly as for first round of enrichment in order to be loaded 
onto filters. For the hybridization, 11 filters were prepared, 3 for 
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MSH2 probes, 3 for MLH1 probes, 2 for S11/S13 probes and 3 
blank filters.  In this experiment 1 filter with MLH1 probes was 
placed into the tube with MSH2 filters and 1filter with MSH2 
probes was placed into the tube with MLH1 filters to act as 
controls. It was estimated that a total of about 1ȝg of DNA was 
loaded onto the filters. The DNA was then crosslinked by 
exposure under 50mJ of UV light. Each tube with filters was 
prehybridized and then hybridized overnight at 65°C with 
captured genomic DNA from first round of enrichment. The 
filters were then stringently washed, placed into 50ȝl of 1x 
buffer IV (AB gene) solution and incubated at 95°C for 5 
minutes. The captured DNA was then amplified at 30 cycles 
using AH1F and AH2F primers and purified by QIAquick PCR 
purification Kit (Qiagen). The PCR product was quantified by 
2% agarose gel in gel electrophoresis. The DNA samples were 
then prepared for MAPH.  Filters were generated with the 
MSH2, MLH1 and S11/S13 probes where only 1ng of DNA was 
loaded but for the control filters 1ȝg of the appropriate DNA 
was loaded. The DNA was crosslinked onto the filters under 
50mJ of UV light. The filters were prehybridized and then 
hybridized with HNPCC probe set (See sections 2.2.2 and 
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2.2.3). Hybridization was followed by stringent washing of 
filters, placement in 50ȝl of 1x buffer and incubation in 95°C for 
5 minutes. The captured DNA was then amplified for 25 cycles 
followed by incubation at 72°C for 40 minutes and prepared for 
ABI electrophoresis analysis at 1kV for 45 seconds.  
 
2.3.4 Single probe amplification assay 
 
In this experiment, new primers were designed as shown in 
Table 7, with the use of UCSC Genome Browser and Primer3 
software in order for specific regions of captured DNA 
sequences to be amplified, and the amount of the captured 
DNA to be estimated and the hybridization efficiency to be 
determined. For each PCR experiment 2ȝl of 10x PCR, 1ȝl of 
10ȝM of the appropriate left primer, 1ȝl of 10ȝM of the 
appropriate right primer, 0.2ȝl of 5000U/ml Taq polymerase 
and 14ȝl of deionised water were mixed.  
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Primer Sequence 
S12 Left TTCCTGTGTACATTTTCTGTTTTT 
S12 Right TATACGTCATTAGGAATAAATGAA 
S13 Left AGAAGTTTAAAATCTTGCTTTCTGA 
S13 Right TTCCAACATTTCAGCCATGA 
S12-S13 Left GATGGAGAAAATTCCCAGTTCTT 
S12-S13 Right CATGAGCCTATATGCAAGGCTA 
L6 Left GCCCCAGTCAGTGCTTAGAA 
L6 Right GGTCCTCCACCTGAACAGAA 
L16 Left GATGCTCCGTTAAAGCTTGC 
L16Right GGTCCTCCACCTGAACAGAA 
 
Table 7. The primers which were used for the amplification and 
capture evaluation of specific regions at MSH2 and MLH1 exons 
which  were used at the selection experiments.  
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2.4 Nanodrop Spectrophotometry 
 
For the accurate measurement of the MSH2 captured DNA 
from second round of enrichment, Nanodrop spectrophotometry 
was applied. For the generation of sufficient DNA product 4 
different amplifications were prepared. Each sample contained 
2ȝl of 10x PCR mix, 1ȝl of A+)SULPHUȝORI$+)SULPHU
0.2ȝl of Taq polymerase, 14ȝl of deionised water and 1ȝl of 
second round of enrichment DNA. The mixes were amplified at 
30 cycles followed by 40 minutes incubation at 72°C.  The 
samples were then purified by QIAquick PCR purification Kit 
(Qiagen). Nanodrop spectrophotometer was then zeroed with 
the use of 1ȝl of elution buffer and then 1ȝl of the purified DNA 
sample was used for the measurement.  
 
2.5 Cloning of enriched DNA  
 
2.5.1 Ligation 
 
Approximately 31ng of enriched DNA was estimated to be 
ligated with 50ng of pGEM-T (Promega). In total three ligations 
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were prepared, the first was with MSH2 enriched DNA the 
second was with control insert DNA 4ng/ȝl (Promega) and the 
third was with deionised water. For the ligation reaction, 1ȝl of 
input DNA, 2ȝl of 10x ligase buffer (500mM Tris-HCl, 100mM 
MgCl2, 10mM ATP, 100mM Dithiothreitol, pH 7.5), 2ȝl of 10mM 
ATP, 1ȝl of 50ng pGEM-T (Promega), 1ȝl of 400,000U/ml T4 
DNA ligase (New England Biolabs) and 13.5ȝl of deionised 
water were mixed for each ligation mix. The samples were 
incubated at room temperature for 1 hour and then were placed 
at 4°C for overnight incubation.  
 
2.5.2 Ethanol Precipitation 
 
To each ligated sample 0.5ȝl of 10mg/ml tRNA(Sigma) was 
added followed by the addition of 60ȝl of EtOH. The samples 
were incubated on ice for 10 minutes and then were centrifuged 
at 13,000rpm for 10 minutes. The supernatant was then 
removed from the pellet and the tubes were spun again for 1 
minute.  The last drops of supernatant were removed and 120ȝl 
of 80% EtOH were added to each tube followed by 
centrifugation at 13,000rpm for 10 minutes. The supernatant 
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was then removed and the tubes were spun for an additional 
minute. The last drops of supernatant were then removed and 
the tubes were left for 5 minutes to air dry before the pellet was 
redissolved in 15ȝl of elution buffer.  
 
2.5.3 Transformation 
 
For the transformation E. coli TOP 10 cells were defrosted from 
-80°C. Cells were then washed in 10% glycerol. The 
supernatant was removed and then the cells were centrifuged 
again for 7 minutes at 7K at 4° C. The washed cells (40ȝl) were 
then electroporated with the addition of 2ȝl of each precipitated 
ligation sample at 12kV/cm (100ȍ, 25ȝl). With the 
electroporation samples were also included a sample with no 
DNA input, and one with 100pg of plasmid ms3 CE10 as 
electroporation control. Once the electroporation was 
completed 500ȝl of SOC medium was added into each sample 
and incubated at 37°C for 1 hour.  During that time 6 plates 
were prepared from 300ml of LB agar with 300ȝl of 50mg/ml 
ampicillin. To each plate before the addition of the 
electroporated samples 25ȝl of 25mg/ml XGal were added in 
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order for possible lac- recombinants to be identified. To the first 
two plates 400ȝl and 100ȝl of electroporated MSH2 DNA was 
added respectively, one with control insert DNA, one with water 
only sample, one with the TOP 10 cells only and one  with 
100pg of ms3 ce10 as electroporation control sample. 
Approximately 500ȝl of the appropriate electroporated samples 
were added to each plate followed by overnight incubation at 
37°C.Once colonies were grown 50ml of SOC were mixed with 
100ȝl of Ampicilin and 5ml of 10x HMFM and from that mix 
100ȝl were placed into each well of a 96-well plate. White 
colonies which indicated recombinant clones were picked and 
placed in each well followed by overnight incubation at 37°C.   
 
2.5.4 Identification of cloned inserts 
 
The grown colonies were PCR amplified directly from cultures 
in the plate. Therefore, as shown in Figure 14, for each sample 
2ȝl of 10x of PCR mix, 1ȝl of 10ȝM 1277primer 
(TGGCGAAAGGGGGATGTGCTG), 1ȝl of 10ȝM PGB primer 
(AGGCGGCCGCACTAGTGAT), 0.2ȝl of 5000U/ml Taq 
polymerase 14ȝl of deionised water and about 0.5ȝ
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culture were mixed and amplified at 30 cycles in a three step 
PCR (95°C for 30 seconds, 60°C for 1 minute and 70°C for 1 
minute). The PCR product was checked on a 2% agarose gel, 
with 10ȝl of the product were mixed with 5ȝl of deionised water 
and 2ȝl of loading dye. The remainly 10ȝl of PCR products 
were purified with the use of AMPure (Agencourt) and eluted in 
40ȝl of deionised water.  
 
Figure 14. Illustration of the position of 1277 and PGB primers in 
correspondence to an inserted sequence. The PGB region is located 
just next to the inserted region, whereas the Primer 1277 which is 
indicated with pink colour is located approximately 140b before the 
insert.   
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2.5.5 Sequencing  
 
Approximately 30ng of each purified sample was sequenced 
with the use of 0.5ȝl of BigDye Terminator v3.1 mix, 3.5ȝl of 
Big Dye sequencing buffer (Applied Biosystems), 0.5ȝl of 10ȝM 
of 1277 primer and 4.5ȝl of deionised water. The samples were 
amplified for 25 cycles of 95°C for 30 seconds, 50° C for 15 
seconds and 60 ° for 4 minutes. The sequenced samples were 
then purified by CleanSEQ (Agencourt).   
Sequencing was followed by bioinformatic analysis where the 
captured sequences were aligned with the human genome with 
the use of UCSC genome browser and BLAST search in order 
the level of enrichment to be estimated. Sequences had to fulfil 
certain criteria in order to be considered as on target 
sequences. The sequences had to be in between AH1F and 
AH2F primers and to contain the sequences of both primers. 
The sequences once were aligned were recorded for their 
position the possible mismatches and the percentage of 
alignment with the sequence of interest.  
 
Page 76 out of 132 
 
Chapter 3 
Results 
 
Filter based hybridization was used for the capture of specific 
subgenomic targets to evaluate its applicability to next- 
generation sequencing analysis. Subsequently, the degree of 
enrichment was assessed using MAPH, specific PCR, and 
(Sanger) sequencing. First, however, amplifiable DNA for 
enrichment has to be produced from the samples to be tested.  
 
3.1 Amplifiable linkered genomic DNA 
 
After electrophoresis on a 2% agarose gel with a 100bp ladder 
500ng/ȝl (New England Biolabs), the sheared genomic DNA 
was estimated to be between 100 to 900bp in length, with the 
greatest concentration of DNA between 300 and 400bp.  
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3.1.1 PCR Efficiency 
 
The genomic DNA, once it was end repaired and ligated, was 
tested in order for the optimal PCR conditions to be identified 
and used in future experiments. The linkered genomic DNA 
samples were amplified for 25 cycles and it was shown that a 
good yield of DNA was produced as illustrated in Figure 15.  
 
 
Figure 15. Genomic DNA was amplified for 25 cycles generating 
significant amount of DNA. The first lane consists of a 100bp DNA 
ladder. 
The samples which had previously amplified well at 25 cycles 
were used at 25 cycles again but different PCR reagents were 
            M                               AF103        TT297    Ligation control 
25 cycles 
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tested as shown in Figure 16. The samples were amplified with 
the use of AB 10 x PCR buffer IV (ABx gene), 10x buffer 
(500mM Tris -HCl pH 8.8, 120mM ammonium sulphate, 50mM 
MgCl2, 74mM 2-mercaptoethanol, 11mM dATP, 11mM dCTP, 
11mM dGTP and 11mM dTTP and 1.25mg/ml BSA), 10 x buffer 
with 10% of HiDi formamide and 10x buffer with 50% of 
glycerol. Gel electrophoresis showed that the PCRs with the 
greatest efficiency were with the HiDi formamide and with the 
BSA input.  
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Figure 16. AF103 and TT297 genomic DNA samples were amplified 
for 25 cycles with the use of different PCR reagents. The lane next to 
the PCR reagents includes the control of the ligation mix.  
The same experiment was repeated but instead of 1 minute at 
95 °C at the denaturation step of PCR, 30 seconds were used 
(Figure 17). With the comparison of the two PCR conditions, it 
was identified that 30 seconds at 95°C instead of 1 minute 
increased the yield of product and therefore in future 
experiments, 10x PCR buffer was used in a three- step PCR 
where the denaturation step at 95°C was for 30 seconds.  
M                   AB                   HiDi                    BSA                Glycerol 
            AF103/TT297   AF103/TT297   AF103/TT297   AF103/TT297 
25 cycles 
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Figure 17. The genomic DNA samples were amplified with the use of 
different PCR reagents for 25 cycles. The PCR reaction conditions 
were altered as 30 seconds were used at 95°C instead of 1 minute.  
The first lane consists of a 100bp DNA ladder. 
The samples were also tested using the previous PCR 
conditions for different numbers of PCR cycles as seen in 
Figure 18. It was found that 20 cycles were sufficient for the 
generation of the maximum amount of DNA.   
 
 
        AF103/TT297   AF103/TT297   AF103/TT297   AF103/TT297    
25 cycles    95°C for 30seconds 
M              AB                   HiDi               BSA                      Glycerol 
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Figure 18. Series of amplifications of genomic DNA samples for 20, 
25 and 30 cycles with the use of BSA and 30 seconds at 95°C for 
PCR conditions. The first lane consists of a 100bp DNA ladder. 
 
3.1.2 MAPH with linkered (unenriched) genomic  
DNA 
 
In the first experiment, 9 filters were prepared, 2 with TT297 
linkered genomic DNA, 2 with AF103 linkered genomic DNA, 4 
filters with approximately 1ȝg of untreated genomic DNA 
(TT297, AF103, AF105, TT298) and 1 blank filter. The data 
from the ABI electrophoresis were normalized and the standard 
deviations of control and of linkered genomic DNA filters were 
M            AF103/TT297       AF103/TT297        AF103/TT297   
                     20                            25                            30 
Page 82 out of 132 
 
compared. The standard deviation of the normalized readings 
of the peak areas from ABI 3100 of the untreated genomic DNA 
samples was estimated at 0.105 and of linkered genomic DNA 
at 0.322. The data from linkered genomic DNA varied more 
than the control genomic DNA, but the extra variation was 
relatively small. In the second experiment, filters for TT297 and 
with AF103 linkered genomic DNA were prepared.  Filters with 
TT297 and AF103 linkered genomic DNA contained 1ȝg of 
DNA amplified for 10 and 20 PCR cycles. Control filters with 
untreated genomic DNA were also prepared exactly as in the 
first experiment. The standard deviation of filters with linkered 
genomic amplified at 10 cycles was estimated at 1.154, from 
the 20 cycles filters at 0.238 and from the control genomic DNA 
at 0.096.  This shows that 20 PCR cycles was the appropriate 
number of cycles for the equal amplification of all the different 
size fragments and therefore better for hybridization and MAPH 
experiments. In the third MAPH experiment, filters with 1ȝg 
TT297 linkered genomic DNA and with AF103 linkered genomic 
DNA were prepared with DNA amplified for 25 PCR cycles. In 
addition to that, filters with untreated genomic DNA were 
prepared exactly as in the previous experiments. The standard 
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deviation of the linkered genomic DNA filters was 0.466 and of 
the control genomic DNA was 0.098. There was variation 
among the probes, which were not equally represented.  
As shown in Figure 19, despite the fact that in 20 PCR cycles 
linkered genomic DNA has the lowest standard deviation, 
smaller probes were not represented as well as the rest of the 
probe set. Even in larger probes the peak height which 
indicates DNA intensity varies among the probes. 
 
 
Figure 19. The comparison of the ABI readings of MAPH with 
linkered genomic DNA amplified for 20 PCR cycles, with untreated 
TT298 genomic DNA which was used as control sample. The DNA 
length in bp is illustrated by x axis and the peak height (intensity of 
DNA) by the y axis.  
 
 
Linkered 
genomic DNA 
Control 
genomic DNA 
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3.2 Enrichment 
 
3.2.1 First Round of Enrichment 
 
Filter based hybridization (Figure 20) was used as a capture 
technique in order to collect the sequences of interest from the 
total genomic DNA for further analysis and evaluation.  
In total 11 filters were prepared, 3 for MSH2, 3 for MLH1, 3 for 
S11/S13 probes and 2 blank filters. Approximately 1ȝg of target 
DNA was denatured and loaded on each filter. The filters were 
hybridized with the denatured linkered genomic DNA, washed 
and denatured followed by amplification and MAPH as shown 
in Figures 1 and 2. The purpose of this experiment was the 
level of enrichment to be evaluated and the percentage of the 
successfully on target sequences to be estimated. Therefore, 
different probes were tested for their representation and 
hybridization efficiency.  
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Figure 20. First round of enrichment experiment, MSH2 and MLH1 
probes were loaded onto filters and were hybridized with sonicated 
and linkered genomic DNA. The selected DNA after 5 minutes at 95°C 
was released into the buffer solution and amplified with AH1F and 
AH2F primers. 
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3.2.2 MAPH 
 
The filter based hybridization technique was used for the 
enrichment of the probes of interest, and MAPH for the 
evaluation of the enrichment. In previous studies, MAPH has 
been used as tool for the identification of potential deletions 
and duplications, but in this project the same method was used 
as evaluation tool. As can be observed in Figure 21, the same 
principle was used as described in Figure 7 (Materials and 
Methods chapter) but instead of untreated genomic DNA, 1ȝg 
of enriched genomic DNA from first round of enrichment was 
loaded onto the filters. MAPH was also repeated by loading 
onto the filters 100ng and 10ng of enriched genomic DNA. The 
ABI electrophoresis results and the level of enrichment are 
illustrated in Table 8. The average readings from 1ȝg of 
untreated genomic DNA were used as the control value. The 
level of enrichment was estimated by the comparison of the 
average peak height of the captured probes with the average 
peak height of the control genomic DNA samples. The level of 
enrichment which is illustrated in the sixth column shows that 
the use of a smaller amount of captured DNA on the filters for 
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MAPH enhances full hybridization and subsequently the 
observed level of enrichment. Also, as can be seen in Figure 
22, where an evaluation of the enrichment of MLH1 and MSH2 
probes is illustrated, the enrichment was successful with the 
sequences of interest to be much more enriched than the 
background DNA. However, the probes were not represented 
equally as smaller probes were generally underrepresented 
compared to the bigger probes.  
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Figure 21. In MAPH, amplified captured genomic DNA from the first 
round of enrichment was loaded onto the filters and hybridized with 
the HNPCC probe set. The resulting captured DNA was amplified and 
analysed after electrophoresis on an ABI 3100. 
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Quantity Target 
DNA 
Average Control 
Average(Untreated 
genomic DNA) 
Average of 
Enriched genomic 
DNA/ 
Control 
Average(Untreated 
genomic DNA) 
Enrichment 
1ȝg MSH2 12149.53 3516.467 3.45 3.45 
1ȝg MSH2 11846.1 3516.467 3.46 3.46 
1ȝg MLH1 8069.211 3516.467 2.29 2.29 
1ȝg MLH1 8291.579 3516.467 2.35 2.35 
1ȝg S11/S13 59711 3516.467 17 17 
1ȝg S11/S13 39463 3516.467 11.2 11.2 
100ng MSH2 109052 3516.467 31 31 
100ng MSH2 95927.59 3516.467 27.27 272.7 
100ng MLH1 72176.26 3516.467 20.52 205.2 
100ng MLH1 76441 3516.467 21.73 217.3 
100ng S11/S13 134993 3516.467 38.38 383.8 
100ng S11/S13 126442 3516.467 35.95 359.5 
10ng MSH2 34683.25 3516.467 9.86 986 
10ng MSH2 60901.36 3516.467 17.31 1731 
10ng MLH1 21944.74 3516.467 6.24 624 
10ng MLH1 43293.89 3516.467 12.31 1231 
10ng S11/S13 76658 3516.467 21.79 2179 
10ng S11/S13 57948 3516.467 16.47 1647 
 
Table 8. The level of enrichment from the first round of enrichment 
experiments. The table illustrates a general overview of the level of 
enrichment at different DNA concentrations.  
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Figure 22. The ABI peaks from MHS2, MLH1 and S11/S13 probes with 
the use of 1ȝg of DNA. The x axis represents the DNA size in bp and 
the y axis the peak height (DNA intensity). It can be clearly seen that 
there is a difference  between the two pictures where different length 
probes were captured. Therefore at the first two pictures, only MSH2 
and MLH1 probes were captured respectively. In the third the 
MSH2 
MLH1 
S11/S13 
MLH1 
MSH2 
S11 S13 
MSH2+MLH1 
1ʅg 
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capture of the two probes S11 and S13 can be seen with relatively 
minor background. The circled peaks on the first picture illustrate 
the presence of traces of MLH1 probes as background DNA, in the 
second picture traces of MSH2 probes as background DNA, and in 
the third picture traces of both MSH2 and MLH1 probes.  
 
3.2.3 Second Round of Enrichment 
 
In this step as shown in Figure 23, captured genomic DNA from 
the first round of enrichment was used for further enrichment by 
hybridization, exactly as in the first round of enrichments with 
MSH2 and MLH1 probes. The filters were washed and 
denatured followed by MAPH and ABI electrophoresis as 
shown in Figures 20 and 21.Also, series of dilutions were 
prepared in order for 1ng, 100pg, and 10pg of second round 
enriched genomic DNA to be loaded onto filters for MAPH. In 
the amplified second round of enrichment DNA it was estimated 
that in every 3ȝl there are approximately 200ng of total DNA. 
Therefore 3ȝl of DNA were diluted into 600ȝl of deionised water 
in order for every 3ȝl to contain 1ng of DNA. Further dilutions 
were made to result in lower inputs, and in every dilution 1ȝl of 
NaOH was added in order for the captured DNA to be 
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denatured. MAPH results from the second round of enrichment 
experiment are shown in Figure 24. MSH2 and MLH1 probes 
can be easily distinguished, although the smaller probes have 
been found to not hybridize as efficiently as the larger probes, 
especially the probes at 152bp and 158bp for MSH2; the 
difference in hybridization efficiency can be seen at 100ng and 
10ng of input where larger probes maintain the good signal in 
contrast with the smaller size probes which almost 
disappeared. Also, even though the input of  DNA was 
decreased 1000 times and 100,000 times the average signal of 
the enriched probes remained higher than with 1ȝg unenriched 
genomic DNA, which not only indicates the successful 
enrichment but also the fact that by decreasing the input DNA, 
the completeness of hybridization is increased.  The level of 
enrichment was estimated and is illustrated in Table 9 where, 
as in Table 8, the average intensity from untreated genomic 
DNA was used as a control value. The level of enrichment is 
illustrated in the sixth column as in first round of enrichment by 
reducing the amount of DNA input in MAPH enrichment is 
increased. An enrichment of 7,040,000 in 10pg of S11/S13 
input was achieved. 
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Figure 23. In the second round of enrichment MSH2 and MLH1 
probes were amplified and loaded onto filters and hybridized with 
amplified genomic DNA captured in the first round of enrichment. 
The captured DNA was amplified and used for MAPH analysis 
followed by ABI electrophoresis.  
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Figure 24. A comparison of the captured probes at various dilutions. 
At lower DNA concentrations it can be observed that smaller size 
probes have very weak signal and also in overall the signal is getting 
weaker as the input DNA concentration is reduced.  
 
 
 
100ng 
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Quantity Target 
DNA 
Average Control 
Average(Untreated 
genomic DNA) 
Average of 
Enriched genomic 
DNA/ 
Control 
Average(Untreated 
genomic DNA) 
Enrichment 
SECOND  ROUND OF  ENRICHMENT 
  
1ng MSH2 72774.07  3516.467 20.75 20750 
1ng MSH2 77572.43  3516.467 22.05 22050 
1ng MLH1 42119.53  3516.467 11.97 11970 
1ng MLH1 47349.47  3516.467 13.46 13460 
1ng S11/S13 132848  3516.467 37.77 37770 
1ng S11/S13 197129  3516.467 56.05 56050 
100pg MSH2 36721.71  3516.467 10.44 104400 
100pg MSH2 34204.5  3516.467 9.72 97200 
100pg MLH1 43320.61  3516.467 12.31 123100 
100pg S11/S13 150182  3516.467 42.70 427000 
100pg S11/S13 124481  3516.467 35.39 353900 
10pg MSH2 15170.43  3516.467 4.31 431000 
10pg MSH2 4000.643  3516.467 1.137 113700 
10pg MLH1 3987.351  3516.467 1.13 113000 
10pg MLH1 3813.563  3516.467 1.08 108000 
10pg S11/S13 84756  3516.467 24.10 2410000 
10pg S11/S13 24799  3516.467 7.05 705000 
10pg S11/S13 108892  3516.467 30.9 3090000 
10pg S11/S13 247792  3516.467  70.4 7040000 
 
Table 9. The level of enrichment in second round of enrichment. The 
level of enrichment is increased as the concentration is reduced with 
maximum enrichment achieved of 7,040,000. The average fragment 
size was about 300bp which is equal to 1/10,000,000 of the genome. 
Therefore 7,040,000 fold enrichment should equate to approximately 
70% of the total DNA captured.  
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3.3 Single- Locus PCR of exonic regions of 
MLH1 and MSH2 genes 
 
3.3.1 Single Probe Amplification Assay 
 
In order for the level of enrichment to be further quantified, 
primers were designed (See Table 7 from Materials and 
Methods) for specific exonic regions, and the captured genomic 
DNA was amplified in various PCR cycles. In every 
amplification, unenriched linkered genomic DNA was also used, 
for the efficiency of the PCR to be estimated as the genomic 
DNA input was known (20 ng/ȝl). Also, captured genomic DNA 
from first and second round of enrichment was amplified for the 
same number of cycles in order the level of enrichment to be 
compared. All the DNA samples were amplified at 20, 23, 25, 
27, 30, 32, 35 and 40 PCR cycles. With the use of a 100bp 
ladder (New England Biolabs), the PCR product was quantified. 
It was estimated for unenriched linkered genomic DNA that 
about 100ng of PCR product were generated after 32 PCR 
cycles. The average size of the sheared DNA fragments was 
approximately 300bp; therefore each fragment is equal to 
1/10,000,000 of the length of the genomic DNA. Therefore any 
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300bp target in 20ng of DNA is represented at a total of 2fg and 
in order for 100ng of that 300bp fragment to be generated; the 
product was increased by 50,000,000 times. It was calculated 
that in every cycle the PCR product is increased by 1.74 times 
as 1.7432 are approximately equal to 5x107 times. 
 
3.3.2 S13 primers 
 
For the first round of enrichment DNA, it was found that 32 
PCR cycles were required for the generation of about 15ng of 
product DNA. Assuming that in every PCR cycle the product 
was increased by 1.74 times, it was estimated that in 1ȝl of first 
round of enrichment DNA S13 exon was presented at 
approximately 0.3fg. On the other hand, second round of 
enrichment DNA required only 20 cycles for the generation of 
approximately 10ng of DNA. Therefore, it was calculated as 
can be seen in Table 10 that in 1ȝl of second round of 
enrichment captured DNA, the S13 exon was represented at 
approximately 0.155pg. 
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3.3.3 S12 primers 
 
For the S12 primer pair it was estimated that in every PCR 
cycle the DNA input is increased by 1.6 times. Therefore it was 
found that 35 cycles were required in order 15ng of DNA to be 
generated for first round of enrichment DNA. It was calculated 
that in 1ȝl of first round of enrichment DNA, 1fg of exon S12 is 
present. On the other hand, as can be observed in Figure 25, 
for second round of enrichment DNA, only 23 PCR cycles were 
required for the generation of 10ng of DNA. Therefore as 
shown in Table 10 in 1ȝl of second round of enrichment DNA, 
S12 exon at approximately 0.2pg was present. 
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Figure 25.  The PCR cycle test with the use of second round and first 
round of enrichment genomic DNA for amplification with S12 
primers. The quantity of DNA was estimated with comparison with 
the 100bp marker (first lane).  
 
3.3.4 L6 and L16 primers 
 
The same experiments were repeated with the use of L6 and 
L16 primers and it was found for L6 that for the generation of 
10ng of DNA 30 and 25 cycles were required for first round and 
second round of enrichment respectively this time using DNA 
enriched by hybridization to MLH1 DNA. Therefore as shown in 
Table 10 in 1ȝl of DNA input there are 1.4fg of L6 exon in the 
first round of enrichment, and 0.246pg for the second round of 
M     20     23     25    27     30      35     40               27       30    32     35    40       
Second Round of Enrichment First Round of Enrichment 
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enrichment. With L16 primers was estimated that in 1ȝl of DNA 
input there were 11fg of L16 exon for first round of enrichment 
DNA, and 0.25pg for second round of enrichment DNA.  
 
3.3.5 Between S12 and S13 
 
Primers were also designed for a region between S12 and S13 
in order for any overlapping sequences captured to be 
identified. It was found that in 1ȝl of second round of 
enrichment DNA, approximately 2.15fg were of fragments from 
that region as shown in Table 10. 
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MSH2 probes AH1F/AH2F 
Primers 
First Round of Enrichment 5fg/ȝl 
Second Round of Enrichment 3.2pg/ȝl 
MSH2 probes S13 primers 
First Round of Enrichment 0.3fg/ȝl 
Second Round of Enrichment 0.155pg/ȝl 
MSH2 probes S12 primers 
First Round of Enrichment 1fg/ȝl 
Second Round of Enrichment 0.2pg/ȝl 
MSH2 probes S12/S13 primers 
First Round of Enrichment - 
Second Round of Enrichment 2.15fg/ȝl 
MLH1 probes L6  primers 
First Round of Enrichment 1.4fg/ȝl 
Second Round of Enrichment 0.246pg/ȝl 
MLH1 probes L16 primers 
First Round of Enrichment 30fg/ȝl 
Second Round of Enrichment 0.25pg/ȝl 
 
Table 10. A summary with the results from the single probe 
amplification assays, together with (top lines) estimates of 
the total amount of DNA present from AH1/AH2 PCR. The 
enriched DNA was amplified and quantified in order for 
their representation to be evaluated. It can be seen that the 
different exons were represented in the captured DNA in 
similar amounts. The data represent the DNA quantity of 
the chosen enriched fragments previously described.  
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3.4 Nanodrop Spectrophotometry 
 
Second round of enrichment genomic DNA for MSH2 probes 
which was previously amplified with AH1F/AH2F primers was 
quantified by gel electrophoresis. A known quantity of herring 
sperm DNA was used in order for the smears to be compared 
and the quantity of genomic DNA to be estimated. However, 
genomic DNA was in a form of smear and subsequently it was 
not possible to be measured with accuracy. Therefore 
Nanodrop spectrophotometry was used so a more accurate 
measurement of the total amount of amplified genomic DNA 
could be achieved. Second round of enrichment genomic DNA 
for MSH2 probes was amplified with AH1F/AH2F primers and 
then purified in order primers and nucleotides to be removed. 
From the purified sample, 1ȝl was used for Nanodrop 
spectrophotometry analysis (See Figure 26)  
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Figure 26.  It was measured that in 1ȝl there are 31.2ng of captured 
DNA. The 260/280 ratio indicate the purity of the sample tested, and 
ratios from 1.8 to 2 are in generally considered as pure.  
 
In total 4 DNA samples were amplified, purified and mixed 
together. Therefore in a mix of 30ȝl there are 935ng of DNA, 
which is approximately 234ng for each DNA sample. For the 
generation of 234ng of DNA 20 cycles were required from a 
1ȝl input. It was estimated that in every PCR cycle the product 
was increased by 1.75 times and therefore the genomic DNA 
captured from the second round of enrichment in 1ȝl was 
calculated to be 3.2pg. Genomic DNA of known size was used 
in order for the value of 1.75 to be estimated; therefore the 
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samples of the same PCR experiment are expected to have 
approximately the same rate as the same reagents were 
used.  Generating 234ng from 3.2pg input requires 
amplification of approximately 73,000 times, and 1.7520 is 
about 73,000. 
 
3.5 Level of enrichment 
 
The average quantity of S12 and S13 probes in 1ȝl of second 
round of enrichment DNA for MSH2 was estimated as 
0.1775pg (S12 0.2pg,  S13 0.155pg). There were 16 probes in 
total for MSH2, therefore assuming equal representation, the 
total amount of these probes in second round of enrichment 
genomic DNA for MSH2 was estimated as (16x 0.1775= 
2.84pg). The total amount of MSH2 second round of 
enrichment DNA per 1ȝl was estimated to be 3.2pg, both by 
Nanodrop spectrophotometry and by AH1/AH2 PCR and 
therefore the successful on-target sequences in this enriched 
genomic DNA are approximately 89% of the total captured 
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sequences. If all the probes were enriched equally, each probe 
should be about 5% of the total on target 89%.  
 
3.6 Sequencing 
 
Second round of enrichment genomic DNA for MSH2 probes, 
was cloned into pGEM-T and 191 clones were sequenced for a 
more direct and accurate measurement of the level of 
enrichment. From the 191 clones, 163 of them were 
successfully sequenced, and 145 of them (89%) were on target 
sequences. In Table 11 and Figure 28 is illustrated that not all 
the probes were equally represented. The smaller size probes 
were underrepresented, and some probes (such as S8 and 
S16) were absent; on the other hand the larger probes were 
better enriched with S3 and S4 representing 22% and 18% 
respectively of all sequences. As can be seen in Figure 27 
where there is an account of the captured probes and the 
region of their coverage, the fragments are overlapping with 
each other covering the total sequence. Also, S3 probe was 
investigated for the presence of any possible SNPs. It was 
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found that the presence of mismatches to the reference 
sequence was due to Taq polymerase low fidelity because 
mismatches were different in overlapping sequences, with no 
repetition. From the non-target sequences there were 5 from 
chromosome 19 at the NFIC gene, 5 unidentified non-human 
sequences, 1 from chromosomes 1, 7, 4 and 11 at ARHGEF12 
gene, 3 sequences between S1 and S2 probe and 1 between 
S15 and S16 probe.  Also the sequences captured were 
estimated to have an average size of 156bp, of which it was 
measured that 132bp were of the sequences of the target. 
Larger probes as mentioned above were better enriched with 
many sequences captured; however, each captured sequence 
was covering on average only 40% of the sequence of interest. 
On the other hand, for smaller probes fewer fragments were 
captured but because of their smaller size and the high 
specificity of the hybridization, the captured sequences were 
covering (on average) 80% for S10 and approximately 70% for 
S6 of the sequence of interest. Also, as can be seen in Figure 
29, GC content was not the most important factor that affects 
the success of the enrichment.   
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Table 11.  The list of the probes captured with their size in base 
pairs and the number of sequences captured for each probe 
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Figure.27 The captured fragments and the region of coverage for S3 
probe (279bp). The top blue line indicates the S3 probe and the 
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black lines the captured fragments. The values on the lines indicate 
the position in base pairs of the fragments within chromosome 2.  
 
 
Figure 28 The correlation between the probe size and the number of 
sequences captured (P = 0.000914). The number of sequences 
captured is increased as the probe size that was used for selection 
is larger. However, the only exception is S1 (338bases) probe which 
was not enriched as well in correlation to its size.  
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Figure 29.  The correlation between the number of sequences 
captured and the GC content of the probes. The number of 
sequences captured has no correlation with GC content (P = 0.6151). 
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Chapter 4 
Discussion 
 
Copy number variations (CNVs) have been demonstrated that 
might be responsible for a wide range of genetic diseases 
(Shaikh et al. 2009). The identification of potential copy number 
variations in genes was a challenge in previous years. So far 
there is an extended record of CNVs proved to have role in 
genetic disease susceptibility. The challenge in this research 
was to establish a solid system for capturing regions in order to 
be sequenced and analysed for sequence variants as well as 
the existence of possible CNVs. This could become a future 
clinical diagnostic tool as CNVs can indicate the genetic 
disease in cases where symptoms are not clear.   
In this project filter-based hybridization was used to enrich the 
sequences of interest (Herman et al. 2009) and MAPH for the 
evaluation of the enriched sequences. In previous studies 
MAPH was used for the capture of the probes of interest and 
investigation of potential deletions or duplications in genomic 
DNA (Armour et al. 2000). The aim of the project was for a 
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number of subgenomic targets to be efficiently enriched and 
evaluated for their level of enrichment in order that the enriched 
DNA could be used efficiently for next-generation sequencing 
analysis. The results confirmed that filter-based hybridization 
with two rounds of enrichment can be a powerful tool for 
enrichment with high specificity and high level. So far in 
previous research, the representation achieved by filter- based 
hybridization of a single round of enrichment and was from 60% 
to approximately 70% (Herman et al. 2009). On the other hand, 
in this project the representation which was achieved with the 
two round of enrichment for the capture of exons of MSH2 gene 
was approximately 90%. The level of enrichment after the use 
of only a single round of enrichment was estimated to be 600 
times less than the enrichment after the second round. 
Therefore by comparison with the data from the MAPH analysis 
it was estimated that the enrichment after a single round was 
going to be approximately 1000 times, which indicates that 
about 0.15% of the total sequences, would contain sequences 
of interest. This is further evidence of how the second round of 
enrichment increased the specificity and the level of 
enrichment.  
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4.1 Generation of Amplifiable linkered 
genomic DNA 
 
The genomic DNA with which the target sequences of interest 
were hybridized was sonicated. Therefore it was randomly 
sheared generating fragments from 100 to 900bp. Sonication 
offered the advantage of random shear at random positions, 
and not a method such as restriction enzymes which cut at 
defined positions generating fragments of known size. Also, the 
random size of the fragments offers the advantage in target 
sequences to have equal possibilities to be captured as many 
fragments with different size will contain the sequences of 
interest. In addition to that, because of the variety in the size of 
the captured genomic DNA many fragments will contain 
overlapping sequences with each other, therefore after 
sequencing the overlapping sequences were an additional tool 
for the accurate recording of the sequence of interest and 
overcoming the limitation of the presence of mutations induced 
during PCR.  
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4.2 Amplification of Genomic DNA 
 
Series of PCR tests followed by MAPH were made in order for 
the best conditions for the amplification of genomic DNA to be 
identified. The aim was to find a PCR cycle number where all 
loci amplified almost equally, but the PCR cycle number at the 
same time was relatively small in order for mismatches which 
are incorporated during PCR to be reduced.  The appropriate 
PCR cycle number was 20 where all the fragments seemed to 
where amplified similarly with a relatively low standard 
deviation.  
 
4.3 MAPH 
 
With the MAPH method and through ABI electrophoresis the 
representation of the captured probes was evaluated and the 
level of enrichment was estimated. However, for both first 
round and second round of enrichment captured genomic DNA, 
a series of dilutions were prepared and less DNA was loaded 
onto MAPH filters. The reduction of captured genomic DNA had 
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as a result the decrease in the number of sequences on the 
filters however the small amount of target DNA usually does not 
deplete the MAPH probes and therefore there was less 
competition among the background  DNA and MAPH probes for 
the hybridization with the 2ng of probe set DNA. In MAPH after 
the reduction of amount of captured DNA on filters, because of 
the more successful hybridization,  there was relatively stronger 
signal, which can be seen in Tables 8 and 9 with 5 times 
stronger signal than the filters with 1ȝg of captured genomic 
DNA  shown in Figures 22 and 24. 
 
4.4 ABI analysis 
 
Captured probes from MAPH were analysed by ABI 
electrophoresis for the evaluation of their representation. The 
untreated genomic DNA samples which were used as controls 
were well captured and the probes equally represented which 
indicated that MAPH worked efficiently. However the probes 
from the first round and second round of enrichment were not 
equally represented, as can be seen in Figure 22. Larger 
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probes were better enriched than smaller probes, with the 
smallest having the weakest signal. This presumably happened 
because genomic DNA was fragmented randomly therefore 
fragments hybridized in random positions with the smaller 
probes and because of the small size of the probes of interest 
only few of the random DNA fragments were properly 
hybridized and not washed off after the washing step. The 
sequencing results support that theory, because on average 
each captured fragment was estimated to cover at least 60% of 
the sequence of interest. However, individual cases were found 
where the captured fragment was covering 12 bases from the 
sequence of interest. 
 
4.5 Single Probe Amplification Assay 
 
Region-specific primers were designed and series of PCR cycle 
tests were made in order the level of enrichment to be 
quantified independently of MAPH. Initially, first and second 
round of enrichment genomic DNA for MSH2 was amplified 
with the AH1F/AH2F primers in order that the total captured 
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sequences could be estimated.  The quantification and 
comparison of the captured DNA between first and second 
round of enrichment revealed the efficiency and the importance 
of the use of second round enrichment hybridization. First-
round enriched genomic DNA was estimated to be 5fg/ȝl on the 
other hand second round enriched DNA was found to be 
3.2pg/ȝl, which is approximately 640 times higher 
concentration. The same experimental DNA was followed by 
using the region-specific primers. As can be seen in Table 10, 
there is a significant difference between the quantity of first and 
second round of enrichment with the concentration of specific 
target in second round of enriched DNA to be approximately 
280 times higher than the first round.  
Second round of enrichment genomic DNA was enriched with 
MSH2 filters, and therefore 3.2pg/ȝl was the quantity of 
captured MSH2 probes. The average of S13 and S12 probes 
was estimated as 0.1775pg/ȝl; and therefore the total amount 
of the 16 MSH2 probes is equal with the 89% of the total 
amount of the enriched genomic DNA.  
 
Page 118 out of 132 
 
4.6 Cloning and Sequencing 
 
The previous percentage was estimated considering that all the 
probes were enriched equally. Therefore a cloning and 
sequencing experiment was undertaken for a more accurate 
measurement of the level of enrichment to be made, and to 
investigate whether all the probes were enriched equally or not. 
Genomic DNA from second round of enrichment with MSH2 
filters was ligated into pGEM-T vector and transformed into 
TOP 10 cells. Once recombinant colonies were grown and 
selected, they were amplified with the use of PGB and 1277 
primers. As it can be seen in Figure 18 (Material and Methods 
chapter), primer 1277 is 161 bases before the inserted 
sequence and PGB after the inserted sequence. These primers 
were selected in order to ensure that full insert sequences, 
including the very start of each insert, were obtained.  
The results from sequencing indicated that approximately 89% 
of the total sequences corresponded to the MSH2 sequences 
of interest. As can be seen in Table 11, the probes were not 
enriched equally, but larger size probes were better enriched 
than smaller probes. This result is supported also with the ABI 
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peaks from MAPH analysis in Figure 22 and 24, where smaller 
probes were underrepresented. The fragment sizes which were 
captured varied from 120 to 180 bp therefore more fragments 
were enriched for larger probes but each fragment was 
covering approximately 47% (S3) of the total sequence. On the 
other hand fewer fragments were enriched for smaller probes 
but each fragment was covering approximately 70% (S6) of the 
total sequence. Subsequently despite the fact that not all 
probes were equally enriched, the approximately similar size of 
the captured fragments resulted in covering the total sequence 
of interest even for the smaller probes where less fragments 
were enriched. The drawback of low enrichment of small size 
probes can be surpassed by designing targets of a certain size 
preferably over 200bp in regions where there are not any 
dispersed repeats, which will contain the sequences that are 
needed to be analysed. In addition to that, it was found that the 
mismatches which were present were due to low fidelity of Taq 
polymerase and not of the presence of SNPs, therefore the use 
of a high fidelity polymerase and fewer PCR cycles could 
surpass this limitation.  
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4.7 Conclusion 
 
In this project 35 exons from MSH2 and MLH1 genes were 
successfully enriched with approximately 90% representation 
for MSH2 probes equivalent to an overall enrichment of 
approximately 600,000 times. The method was quick with 
relatively low cost and proved to be a powerful tool for enriching 
subgenomic targets. The high specificity of the technique with 
the enriched fragments to cover successfully the sequences of 
interest suggests that it could be used as a future diagnostic 
tool where specific regions are required to be analysed by next 
generation sequencing. MLH1 probes in the MAPH and single 
locus PCR experiments appeared to be enriched similarly to 
MSH2 probes, and therefore in future experiments both MSH21 
and MLH1 can be sequenced in order for an accurate 
comparison to be made. Also, in future research a higher 
number of samples can be sequenced so statistical error can 
be reduced, and estimation from more samples can be made. 
In addition to that, in this project 35 exons in total were 
enriched from MLH1 and MSH2 genes, and in further research 
a bigger fraction of the genome could be tried to be enriched by 
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enrichment of higher number of target sequences in a single 
experiment.  
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